FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300689903> ?p ?o ?g. }

• W4300689903 endingPage "231" @default.
• W4300689903 startingPage "227" @default.
• W4300689903 abstract "Helicobacter pylori (H. pylori) infection is highly prevalent in Portugal and its eradication is formally recommended. However, the indiscriminate use of antimicrobials has led to a drastic rise in antibiotic resistance, with the failure of traditional eradication schemes. A single-capsule bismuth-based quadruple therapy became recently available in Portugal. This study aims to evaluate the efficacy and safety of a bismuth-based quadruple therapy as a second-line or rescue therapy.This was a multicentric study. All consecutive patients that were treated with bismuth-based quadruple therapy, as second-line or salvage treatment between July 2017 and April 2019 were enrolled. Their medical records were reviewed and clinical and laboratorial parameters, as well as data on treatment efficacy and adverse events were retrieved. Patients were also contacted by phone after treatment to confirm compliance, adverse events, and global satisfaction with this specific therapy.A total of 151 subjects were included (female-68.9%; mean age-56 ± 13.5 years). Patients were previously submitted to 212 eradication schemes (Median-1; 1-5; IQR:4): 33.5% triple clarithromycin-based, 25% sequential, 7.5% concomitant, 5.2% others, and in 28.8% it was not possible to know the previous eradication scheme(s) followed by the patient. The PPI of choice was esomeprazole (39.7%), followed by omeprazole (27.8%). Compliance was achieved in 93.4% and the overall eradication rate was 90.1% (95% CI: 84.6-94.2). Treatment-related adverse effects were experienced by 63 patients (41.7%; 95% CI: 34-49.7), being mild in 29, moderate in 19, and severe in 15. The main drawbacks of the treatment, from the patient's perspective, were the high price (47%) and the adverse effects (16.6%). Failure to eradicate H. pylori was correlated with the following: previous rifabutin-based scheme (0 vs. 100%; p = 0.010) and a higher number of previous treatment schemes (1.5 ± 0.7 vs. 2.3 ± 1.2; p < 0.001).In this South-European country a single-capsule bismuth-based quadruple therapy is an excellent option as a second-line or rescue therapy, with acceptable compliance and side effects." @default.
• W4300689903 created "2022-10-04" @default.
• W4300689903 creator A5015456712 @default.
• W4300689903 creator A5025800756 @default.
• W4300689903 creator A5028218730 @default.
• W4300689903 creator A5040666746 @default.
• W4300689903 creator A5040669857 @default.
• W4300689903 creator A5043809288 @default.
• W4300689903 creator A5043956769 @default.
• W4300689903 creator A5054977842 @default.
• W4300689903 creator A5077822736 @default.
• W4300689903 creator A5081463161 @default.
• W4300689903 date "2022-10-03" @default.
• W4300689903 modified "2023-09-26" @default.
• W4300689903 title "Single-capsule bismuth-based quadruple therapy as a rescue therapy for <i>Helicobacter pylori</i> eradication" @default.
• W4300689903 cites W171478449 @default.
• W4300689903 cites W1931029373 @default.
• W4300689903 cites W1964652414 @default.
• W4300689903 cites W1972686135 @default.
• W4300689903 cites W1978729610 @default.
• W4300689903 cites W1983947605 @default.
• W4300689903 cites W1999824547 @default.
• W4300689903 cites W2004382789 @default.
• W4300689903 cites W2004457911 @default.
• W4300689903 cites W2008146922 @default.
• W4300689903 cites W2020821171 @default.
• W4300689903 cites W2025026187 @default.
• W4300689903 cites W2063563581 @default.
• W4300689903 cites W2064401560 @default.
• W4300689903 cites W2065338120 @default.
• W4300689903 cites W2069378448 @default.
• W4300689903 cites W2149709781 @default.
• W4300689903 cites W2152211277 @default.
• W4300689903 cites W2165886643 @default.
• W4300689903 cites W2166252874 @default.
• W4300689903 cites W2168083201 @default.
• W4300689903 cites W2170048761 @default.
• W4300689903 cites W2171482459 @default.
• W4300689903 cites W2379074562 @default.
• W4300689903 cites W2415250978 @default.
• W4300689903 cites W2512497579 @default.
• W4300689903 cites W2527848138 @default.
• W4300689903 cites W2608096504 @default.
• W4300689903 cites W2809220610 @default.
• W4300689903 doi "https://doi.org/10.1080/00365521.2022.2119097" @default.
• W4300689903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36189844" @default.
• W4300689903 hasPublicationYear "2022" @default.
• W4300689903 type Work @default.
• W4300689903 citedByCount "0" @default.
• W4300689903 crossrefType "journal-article" @default.
• W4300689903 hasAuthorship W4300689903A5015456712 @default.
• W4300689903 hasAuthorship W4300689903A5025800756 @default.
• W4300689903 hasAuthorship W4300689903A5028218730 @default.
• W4300689903 hasAuthorship W4300689903A5040666746 @default.
• W4300689903 hasAuthorship W4300689903A5040669857 @default.
• W4300689903 hasAuthorship W4300689903A5043809288 @default.
• W4300689903 hasAuthorship W4300689903A5043956769 @default.
• W4300689903 hasAuthorship W4300689903A5054977842 @default.
• W4300689903 hasAuthorship W4300689903A5077822736 @default.
• W4300689903 hasAuthorship W4300689903A5081463161 @default.
• W4300689903 hasConcept C126322002 @default.
• W4300689903 hasConcept C141071460 @default.
• W4300689903 hasConcept C197934379 @default.
• W4300689903 hasConcept C2776409635 @default.
• W4300689903 hasConcept C2776962512 @default.
• W4300689903 hasConcept C2777498785 @default.
• W4300689903 hasConcept C2778204628 @default.
• W4300689903 hasConcept C2779384505 @default.
• W4300689903 hasConcept C71924100 @default.
• W4300689903 hasConcept C90924648 @default.
• W4300689903 hasConceptScore W4300689903C126322002 @default.
• W4300689903 hasConceptScore W4300689903C141071460 @default.
• W4300689903 hasConceptScore W4300689903C197934379 @default.
• W4300689903 hasConceptScore W4300689903C2776409635 @default.
• W4300689903 hasConceptScore W4300689903C2776962512 @default.
• W4300689903 hasConceptScore W4300689903C2777498785 @default.
• W4300689903 hasConceptScore W4300689903C2778204628 @default.
• W4300689903 hasConceptScore W4300689903C2779384505 @default.
• W4300689903 hasConceptScore W4300689903C71924100 @default.
• W4300689903 hasConceptScore W4300689903C90924648 @default.
• W4300689903 hasIssue "3" @default.
• W4300689903 hasLocation W43006899031 @default.
• W4300689903 hasLocation W43006899032 @default.
• W4300689903 hasOpenAccess W4300689903 @default.
• W4300689903 hasPrimaryLocation W43006899031 @default.
• W4300689903 hasRelatedWork W2050498853 @default.
• W4300689903 hasRelatedWork W2076555171 @default.
• W4300689903 hasRelatedWork W2224090209 @default.
• W4300689903 hasRelatedWork W2351226079 @default.
• W4300689903 hasRelatedWork W2363799601 @default.
• W4300689903 hasRelatedWork W2370230395 @default.
• W4300689903 hasRelatedWork W2378262714 @default.
• W4300689903 hasRelatedWork W2383973837 @default.
• W4300689903 hasRelatedWork W2391721068 @default.
• W4300689903 hasRelatedWork W3141464105 @default.
• W4300689903 hasVolume "58" @default.
• W4300689903 isParatext "false" @default.
• W4300689903 isRetracted "false" @default.

• next